Skip to Main Content
Try STAT+ TODAY
Trending:
Biotech
Pharmalot
STAT+
Coronavirus
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

This biotech is betting dietary changes can reshape cancer care. Even if it works, can Faeth make a profit?

  • Jonathan Wosen

By Jonathan Wosen July 19, 2022

Reprints
Faeth designs specialized diets for cancer patients, which can include saag with collard greens and ginger garlic butter. Courtesy Faeth Therapeutics

For all the advances oncology researchers have made in genomics and precision medicine, one of the most basic questions for cancer patients remains one of the least understood.

What should I eat?

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Jonathan Wosen

Jonathan Wosen

West Coast Biotech & Life Sciences Reporter

Jonathan Wosen is STAT’s West Coast Biotech & Life Sciences Reporter

Tags

Create a display name to comment

This name will appear with your comment

Will low-dose vaccination stretch the monkeypox vaccine supply, or…
Will low-dose vaccination stretch the monkeypox vaccine supply, or backfire?
As billionaires race to fund anti-aging projects, a much-discussed…
As billionaires race to fund anti-aging projects, a much-discussed trial goes overlooked
In a massive victory for Democrats, Medicare is poised…
In a massive victory for Democrats, Medicare is poised to negotiate drug prices
Pharmalittle: Pfizer to test a Lyme disease vaccine; only…
Pharmalittle: Pfizer to test a Lyme disease vaccine; only monkeypox drug in the U.S. is hard…
With Pfizer deal, Global Blood CEO sees opportunity to…
With Pfizer deal, Global Blood CEO sees opportunity to reach sickle cell patients globally
For the second time, Pfizer tries a warranty in…
For the second time, Pfizer tries a warranty in response to concerns over high drug costs

Recommended Stories